Boanmycin, also referred to as bleomycin A6, belongs to the antineoplastic antibiotic class of drugs and is primarily utilized in chemotherapy regimens for the treatment of various malignancies, including… Read more
Boanmycin, also referred to as bleomycin A6, belongs to the antineoplastic antibiotic class of drugs and is primarily utilized in chemotherapy regimens for the treatment of various malignancies, including lung, head and neck, and ovarian cancers. The compound functions by inducing cellular senescence and apoptosis, which effectively slows or stops the proliferation of cancer cells. This category provides essential reference standards for Boanmycin API, alongside its pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these high-quality materials for precise impurity profiling, method validation, and rigorous quality control protocols. By utilizing these characterized standards, researchers and analytical chemists can ensure the accuracy of their chromatographic assays and regulatory compliance during the development and testing of antineoplastic drug formulations.